- Home
- SRRK vs MSM Comparison
SRRK vs MSM Comparison
Compare SRRK & MSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRRK
- MSM
- Stock Information
- Founded
- SRRK 2012
- MSM 1941
- Country
- SRRK United States
- MSM United States
- Employees
- SRRK N/A
- MSM N/A
- Industry
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- MSM Industrial Machinery/Components
- Sector
- SRRK Health Care
- MSM Industrials
- Exchange
- SRRK Nasdaq
- MSM Nasdaq
- Market Cap
- SRRK 4.2B
- MSM 4.7B
- IPO Year
- SRRK 2018
- MSM 1995
- Fundamental
- Price
- SRRK $43.07
- MSM $80.98
- Analyst Decision
- SRRK Strong Buy
- MSM Hold
- Analyst Count
- SRRK 7
- MSM 5
- Target Price
- SRRK $40.43
- MSM $81.00
- AVG Volume (30 Days)
- SRRK 1.2M
- MSM 494.8K
- Earning Date
- SRRK 11-12-2024
- MSM 01-07-2025
- Dividend Yield
- SRRK N/A
- MSM 4.21%
- EPS Growth
- SRRK N/A
- MSM N/A
- EPS
- SRRK N/A
- MSM 4.58
- Revenue
- SRRK N/A
- MSM $3,820,951,000.00
- Revenue This Year
- SRRK N/A
- MSM N/A
- Revenue Next Year
- SRRK N/A
- MSM $4.68
- P/E Ratio
- SRRK N/A
- MSM $17.76
- Revenue Growth
- SRRK N/A
- MSM N/A
- 52 Week Low
- SRRK $6.76
- MSM $75.05
- 52 Week High
- SRRK $46.19
- MSM $104.76
- Technical
- Relative Strength Index (RSI)
- SRRK 69.26
- MSM 40.22
- Support Level
- SRRK $40.95
- MSM $80.64
- Resistance Level
- SRRK $44.22
- MSM $83.66
- Average True Range (ATR)
- SRRK 2.57
- MSM 1.69
- MACD
- SRRK -0.12
- MSM -0.38
- Stochastic Oscillator
- SRRK 73.14
- MSM 12.31
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.
About MSM MSC Industrial Direct Company Inc.
MSC Industrial Direct is one of the largest industrial distributors with a focus on metalworking and maintenance, repair, and operations products and services. The company offers over 2 million products through its distribution network, which has 11 fulfillment centers. Although MSC has a presence in Canada, Mexico, and the United Kingdom, it primarily operates in the United States. In fiscal 2023, 95% of the firm's $4.0 billion of sales was generated in the US.